NCT06220032 2026-01-05HO170DLBCLStichting Hemato-Oncologie voor Volwassenen NederlandPhase 3 Recruiting324 enrolled
NCT03003520 2023-05-22A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell LymphomaCelgenePhase 2 Completed46 enrolled 20 charts